Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images-Reference-Cited by-同舟云学术

Deep learning identifies morphological patterns of homologous recombination deficiency in luminal breast cancers from whole slide images

Published:2022-12 Issue:12 Volume:3 Page:100872
ISSN:2666-3791
Container-title:Cell Reports Medicine
language:en
Short-container-title:Cell Reports Medicine

Author:

Lazard Tristan,Bataillon Guillaume,Naylor Peter,Popova Tatiana,Bidard François-Clément,Stoppa-Lyonnet Dominique,Stern Marc-Henri,Decencière Etienne,Walter Thomas,Vincent-Salomon Anne

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference53 articles.

1. Contemporary outcomes of metastatic breast cancer among 22, 000 women from the multicentre ESME cohort 2008–2016;Deluche;Eur. J. Cancer,2020

2. ESMO recommendations on predictive biomarker testing for homologous recombination deficiency and PARP inhibitor benefit in ovarian cancer;Miller;Ann. Oncol.,2020

3. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase;Bryant;Nature,2005

4. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy;Farmer;Nature,2005

5. Tbcrc 048: phase II study of olaparib for metastatic breast cancer and mutations in homologous recombination-related genes;Tung;J. Clin. Oncol.,2020

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Publicly available datasets of breast histopathology H&E whole-slide images: A scoping review;Journal of Pathology Informatics;2024-12

2. Probing the relevance of BRCA1 and BRCA2 germline pathogenic variants beyond breast and ovarian cancer;JNCI: Journal of the National Cancer Institute;2024-08-22

3. Weakly-supervised deep learning models enable HER2-low prediction from H &E stained slides;Breast Cancer Research;2024-08-19

4. Current HRD assays in ovarian cancer: differences, pitfalls, limitations, and novel approaches;Frontiers in Oncology;2024-08-16

5. Deep Learning Artificial Intelligence Predicts Homologous Recombination Deficiency and Platinum Response From Histologic Slides;Journal of Clinical Oncology;2024-07-31